Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR

Autor: J M Cayuela, BJ Milner, Stéphane Mazoua, Elisabeth Oppliger Leibundgut, Linda Fletcher, Heike Pfeifer, Tomáš Jurček, E Gineikienė, P. Waits, Susanna Akiki, G Wilson, J Farrugia, H El Housni, Ugur Ozbek, D Wren, F. Lin, Tomasz Sacha, Hajnalka Andrikovics, S Chudleigh, Letizia Foroni, Stefanie Trapmann, Petra Johnels, Gareth Gerrard, Thomas Lion, M. Jansson, Katerina Zoi, Hendrik Emons, K. Raudsepp, Gisela Barbany, D A Nymoen, H Schimmel, J Ziermann, Nancy Boeckx, Mark Catherwood, Sandrine Hayette, G Romeo, Helen E. White, R Ganderton, Filomena Daraio, G. Mitterbauer-Hohendanner, Philippe Corbisier, Claude Preudhomme, Andreas Hochhaus, Martin C. Müller, P A Merle, V H J van der Velden, M Nagar, Victoria J. Hall, Lihui Wang, Theis Lange, Tim Clench, T Pajič, Stéphanie Dulucq, D-W Kim, Nicholas C.P. Cross, Josep F. Nomdedeu, Rodica Talmaci, Kateřina Machová Poláková, A Bench, Liesbet Deprez, T Touloumenidou, G Nickless, Veli Kairisto, Barbara Izzo, Dolors Colomer, Aytug Kizilors, Giovanni Martinelli, Renata Zadro, Anni Aggerholm, S McCarron, E Wilkinson

Publikováno v: Leukemia, 29(2), 369-376. Nature Publishing Group
Leukemia
White, H; Deprez, L; Corbisier, P; Hall, V; Lin, F; Mazoua, S; Trapmann, S; Aggerholm, A; Andrikovics, H; Akiki, S; Barbany, G; Boeckx, N; Bench, A; Catherwood, M; Cayuela, J-M; Chudleigh, S; Clench, T; Colomer, D; Daraio, F; Dulucq, S; ... (2015). A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR. Leukemia, 29(2), pp. 369-376. Nature Publishing Group 10.1038/leu.2014.217
Leukemia, 29 (2
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
White, H, Deprez, L, Corbisier, P, Hall, V, Lin, F, Mazoua, S, Trapmann, S, Aggerholm, A, Andrikovics, H, Akiki, S, Barbany, G, Boeckx, N, Bench, A, Catherwood, M, Cayuela, J-M, Chudleigh, S, Clench, T, Colomer, D, Daraio, F, Dulucq, S, Farrugia, J, Fletcher, L, Foroni, L, Ganderton, R, Gerrard, G, Gineikienė, E, Hayette, S, El Housni, H, Izzo, B, Jansson, M, Johnels, P, Jurcek, T, Kairisto, V, Kizilors, A, Kim, D-W, Lange, T, Lion, T, Polakova, K M, Martinelli, G, McCarron, S, Merle, P A, Milner, B, Mitterbauer-Hohendanner, G, Nagar, M, Nickless, G, Nomdedéu, J, Nymoen, D A, Leibundgut, E O, Ozbek, U, Pajič, T, Pfeifer, H, Preudhomme, C, Raudsepp, K, Romeo, G, Sacha, T, Talmaci, R, Touloumenidou, T, Van der Velden, V H J, Waits, P, Wang, L, Wilkinson, E, Wilson, G, Wren, D, Zadro, R, Ziermann, J, Zoi, K, Müller, M C, Hochhaus, A, Schimmel, H, Cross, N C P & Emons, H 2015, ' A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR ', Leukemia, vol. 29, no. 2, pp. 369-76 . https://doi.org/10.1038/leu.2014.217
White, H, Deprez, L, Corbisier, P, Hall, V, Lin, F, Mazoua, S, Trapmann, S, Aggerholm, A, Andrikovics, H, Akiki, S, Barbany, G, Boeckx, N, Bench, A, Catherwood, M, Cayuela, J M, Chudleigh, S, Clench, T, Colomer, D, Daraio, F, Dulucq, S, Farrugia, J, Fletcher, L, Foroni, L, Ganderton, R, Gerrard, G, Gineikiene, E, Hayette, S, El Housni, H, Izzo, B, Jansson, M, Johnels, P, Jurcek, T, Kairisto, V, Kizilors, A, Kim, D W, Lange, T, Lion, T, Polakova, K M, Martinelli, G, McCarron, S, Merle, P A, Milner, B, Mitterbauer-Hohendanner, G, Nagar, M, Nickless, G, Nomdedeu, J, Nymoen, D A, Leibundgut, E O, Ozbek, U, Pajic, T, Pfeifer, H, Preudhomme, C, Raudsepp, K, Romeo, G, Sacha, T, Talmaci, R, Touloumenidou, T, van der Velden, V H J, Waits, P, Wang, L, Wilkinson, E, Wilson, G, Wren, D, Zadro, R, Ziermann, J, Zoi, K, Mueller, M C, Hochhaus, A, Schimmel, H, Cross, N C P & Emons, H 2015, ' A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR ', Leukemia, vol. 29, no. 2, pp. 369-376 . https://doi.org/10.1038/leu.2014.217

Serial quantification of BCR-ABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a substantial variation in results reported by different laboratories. To improve comparability, an internationally accepted plasm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91317b239c9428278b210898c146989b
https://lirias.kuleuven.be/handle/123456789/471833

Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.

Autor: Hovorkova L; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Winkowska L; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Skorepova J; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Krumbholz M; Pediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany., Benesova A; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Polivkova V; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Alten J; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany., Bardini M; Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Meyer C; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe-University, Frankfurt, Germany., Kim R; Hematology laboratory, AP-HP, Saint-Louis hospital, Université Paris-Cité, Paris, France., Trahair TN; Children's Cancer Institute, Randwick, Australia.; School of Women's and Children's Health, School of Medicine, University of NSW, Sydney, Australia.; Kids Cancer Centre, Sydney Children's Hospital Randwick, Sydney, Australia., Clappier E; Hematology laboratory, AP-HP, Saint-Louis hospital, Université Paris-Cité, Paris, France., Chiaretti S; Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Henderson M; Children's Cancer Institute, Randwick, Australia.; School of Women's and Children's Health, School of Medicine, University of NSW, Sydney, Australia., Sutton R; Children's Cancer Institute, Randwick, Australia.; School of Women's and Children's Health, School of Medicine, University of NSW, Sydney, Australia., Sramkova L; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Stary J; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Polakova KM; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Marschalek R; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe-University, Frankfurt, Germany., Metzler M; Pediatric Oncology and Hematology, Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany., Cazzaniga G; Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Medical Genetics, School of Medicine and Surgery, Univ. Milano Bicocca, Monza, Italy., Cario G; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany., Trka J; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Zaliova M; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic., Zuna J; CLIP - Childhood Leukaemia Investigation Prague, Prague, Czech Republic. JAN.ZUNA@LFMOTOL.CUNI.CZ.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University/University Hospital Motol, Prague, Czech Republic. JAN.ZUNA@LFMOTOL.CUNI.CZ.

Publikováno v: Molecular cancer [Mol Cancer] 2024 Jul 05; Vol. 23 (1), pp. 138. Date of Electronic Publication: 2024 Jul 05.

Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.

Autor: Silvestri G; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Trotta R; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland., Stramucci L; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Ellis JJ; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Harb JG; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Neviani P; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Wang S; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland., Eisfeld AK; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Walker CJ; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Zhang B; Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, California., Srutova K; Institute of Hematology and Blood Transfusion, University of Prague, Prague, Czech Republic., Gambacorti-Passerini C; Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy., Pineda G; Department of Health Sciences, School of Health and Human Services, National University, San Diego, California., Jamieson CHM; Department of Medicine and Moores Cancer Center, University of California, San Diego, La Jolla, California., Stagno F; Division of Hematology and Unit of Medical Oncology, A.O.U. 'Policlinico-Vittorio Emanuele', University of Catania, Catania, Italy., Vigneri P; Division of Hematology and Unit of Medical Oncology, A.O.U. 'Policlinico-Vittorio Emanuele', University of Catania, Catania, Italy., Nteliopoulos G; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom., May PC; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom., Reid AG; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom., Garzon R; Department of Molecular Virology Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Roy DC; Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada., Moutuou MM; Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada., Guimond M; Department of Hematology and Cellular Therapy Laboratory, Hôpital Maisonneuve-Rosemont, University of Montreal, Montreal, Quebec, Canada., Hokland P; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Deininger MW; Division of Hematology and Hematologic Malignancies and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Fitzgerald G; Center for Advanced Fetal Care University, University of Maryland School of Medicine, Baltimore, Maryland., Harman C; Center for Advanced Fetal Care University, University of Maryland School of Medicine, Baltimore, Maryland., Dazzi F; Division of Cancer Studies, Rayne Institute, King's College London, London, United Kingdom., Milojkovic D; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom., Apperley JF; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom., Marcucci G; Division of Hematopoietic Stem Cell and Leukemia Research, City of Hope National Medical Center, Duarte, California., Qi J; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Polakova KM; Institute of Hematology and Blood Transfusion, University of Prague, Prague, Czech Republic., Zou Y; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Fan X; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Baer MR; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland., Calabretta B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Perrotti D; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. dperrotti@som.umaryland.edu.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland.; Department of Haematology, Hammersmith Hospital, Imperial College London, London, United Kingdom.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.

Publikováno v: Blood cancer discovery [Blood Cancer Discov] 2020 Jul; Vol. 1 (1), pp. 48-67.

Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target.

Autor: Toman O; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic., Kabickova T; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic., Vit O; BIOCEV, First Faculty of Medicine, Charles University in Prague, CZ-25250 Vestec, Czech Republic., Fiser R; Department of Genetics and Microbiology, Faculty of Natural Sciences, Charles University in Prague, CZ-12843 Prague, Czech Republic., Polakova KM; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic., Zach J; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic., Linhartova J; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic., Vyoral D; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic., Petrak J; Institute of Hematology and Blood Transfusion, CZ-12820 Prague 2, Czech Republic.

Publikováno v: Oncology reports [Oncol Rep] 2016 Sep; Vol. 36 (3), pp. 1258-68. Date of Electronic Publication: 2016 Jul 18.